These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 375959)

  • 1. Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
    Clausen N; Damsgaard T; Mellemgaard K
    Br J Clin Pharmacol; 1979 Apr; 7(4):379-83. PubMed ID: 375959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.
    van Herwaarden CL; Binkhorst RA; Fennis JF; van't Laar A
    Br Heart J; 1979 Jan; 41(1):99-105. PubMed ID: 371643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-adrenoceptor blockade on exercise performance and metabolism.
    Lundborg P; Aström H; Bengtsson C; Fellenius E; von Schenck H; Svensson L; Smith U
    Clin Sci (Lond); 1981 Sep; 61(3):299-305. PubMed ID: 7261552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis.
    Syvälahti E; Lammintausta R; Iisalo E; Kanto J
    Ann Clin Res; 1977 Oct; 9(5):292-5. PubMed ID: 616215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
    Wright AD; Barber SG; Kendall MJ; Poole PH
    Br Med J; 1979 Jan; 1(6157):159-61. PubMed ID: 369646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM; Singh BN; Ambler PK; Dorrington R
    Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Adrenoceptor blockers, plasma-potassium, and exercise.
    Carlsson E; Fellenius E; Lundborg P; Svensson L
    Lancet; 1978 Aug; 2(8086):424-5. PubMed ID: 79785
    [No Abstract]   [Full Text] [Related]  

  • 10. Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.
    Lepäntalo MJ; Tötterman KJ
    Int Angiol; 1985; 4(2):225-8. PubMed ID: 3831144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
    Lund-Johansen P; Ohm OJ
    Br J Clin Pharmacol; 1977 Apr; 4(2):147-51. PubMed ID: 861129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metoprolol and propranolol on lipid metabolism.
    Bielmann P; Leduc G
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):378-82. PubMed ID: 500259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of blood pressure and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise in hypertensive patients.
    Virtanen K; Jänne J; Frick MH
    Eur J Clin Pharmacol; 1982; 21(4):275-9. PubMed ID: 7056271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective and non-selective beta-blockade in renin release.
    Lammintausta R; Syvälahti E; Iisalo E; Kanto J; Mäntylä R
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):489-96. PubMed ID: 202141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenoceptor blockade on carbohydrate metabolism during exercise--comparison of pindolol and metoprolol.
    Dorow P
    Br J Clin Pharmacol; 1982; 13(Suppl 2):429S-430S. PubMed ID: 7104156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.